Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Abbott

2025 Boston Marathon: Sharon Lokedi Shatters Course Record in Dominant Win

Lokedi broke the course record with a time of 2:17:22.

Sports Illustrated

Tariff-Resistant Abbott Laboratories on Track for New Highs

Abbott Laboratories stock price is on track to hit a new high in 2025 and could do it before the end of the first half. Dividends and buybacks help.

MarketBeat

Abbott Elementary is Hulu's #3 most-watched show – here are 3 more comedies with over 90% on Rotten Tomatoes to stream

It's nearly the end of term for Abbott Elementary season 4, but school's in for these three comedies.

TechRadar

From analysis to the latest developments in health,
read the most diverse news in one place.

Here’s What to Expect From Abbott Laboratories’ Next Earnings Report

Abbott Laboratories is expected to announce its first-quarter results this month, and analysts predict a single-digit growth in the company’s bottom-line figure.

Barchart

Jake Arnold's L.A.-meets-London outdoor collection with Crate & Barrel is giving me the motivation to springboard my new season patio makeover

When the inspo is this good, you want to buy into it immediately

Homes & Gardens

Nearly 20 infant formulas found to contain toxic lead, arsenic, or both. Here's how parents can keep babies safe

“We really want these results to be empowering for parents,” said Consumer Reports, which tested 41 types of baby formula.

Fortune

Is Abbott Laboratories Stock Outperforming the Dow?

Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

MarketBeat

Earnings Preview: What to Expect From Abbott's Report

Abbott will release its fourth-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.

Barchart

Love Dividends? 2 Passive Income Stocks to Scoop Up Now.

These consistent dividend-paying stocks could be a good addition to your portfolio.

Barchart

How Abbott Labs Became a Dividend Growth Investor's Dream

Abbott Laboratories is one of the best dividend stocks to buy today: here's why.

Barchart

3 Healthcare Stocks to Buy Now for a Healthy Portfolio in 2025

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical technology. Hence, investors might consider investing in healthcare stocks, Eli Lilly (LLY), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT) for a healthy portfolio in 2025. Read more….

StockNews.com

Abbott Elementary celebrates the holidays with two new episodes tonight, December 4

Abbott Elementary season 4 is winding down the year with two new holiday episodes on December 4. Here’s what you need to know about the special event.

WhatToWatch

Is Abbott Laboratories Stock Underperforming the Nasdaq?

Despite Abbott Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

WhatToWatch

Why Abbott Elementary is not new tonight, November 27

Abbott Elementary is not new tonight, November 27. Here’s when fans can expect to see another new episode.

Barchart

What Are Wall Street Analysts' Target Price for Abbott Laboratories Stock?

Despite Abbott Laboratories’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.

The Guardian - UK

‘If they don’t get care, they die’: the woman who runs the world’s largest kidney dialysis company

Helen Giza of FME is excited about the possibilities new drugs such as Ozempic could offer for renal patients

Salon

How to ensure girls stay in STEM

Sexism in science and tech persists. We must do more to tackle it

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Robotics Stocks Powering the Automation Revolution

Robotics is pivotal in the automation revolution, driving substantial growth in diverse sectors like air defense and healthcare. Therefore, it could be wise to consider fundamentally strong robotics stocks like RTX (RTX), Stryker (SYK), and Medtronic (MDT). Read on.

Barchart

Abbott's Quarterly Earnings Preview: What You Need to Know

Abbott is all set to release its third-quarter earnings later this month, and analysts expect a single-digit profit increase.

International Business Times

'Virus Hunters' Track Threats To Head Off Next Pandemic

A global network of doctors and laboratories is working to pinpoint emerging viral threats, including many driven by climate change, in a bid to head off the world's next pandemic.

The Conversation

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

StockNews.com

3 MedTech Stocks Revolutionizing Healthcare

MedTech stocks are at the forefront of revolutionizing healthcare with the dynamic growth potential of technology. Amid this backdrop, it could be wise to consider investing in companies like Medtronic (MDT), STERIS (STE), and Hologic (HOLX), which are transforming the way healthcare is delivered and tailoring it to individual patient…

Barchart

3 Recession-Proof Dividend Kings to Buy For a Lifetime of Income

Discover three proven, quality companies you can own to get through a looming recession.

Barchart

Is Abbott Stock Underperforming the S&P 500?

Abbott's shares have underperformed the broader S&P 500 this year, but analysts are highly bullish on the stock's potential.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.